SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT

NEW YORK, March 1, 2022

The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On February 7, 2022, SelectQuote reported its financial results for the second quarter of fiscal year 2022.  Among other items, SelectQuote reported a quarterly loss of $0.84 per share and a 45% year-over-year revenue decline.  The Company's Chief Executive Officer Tim Danker attributed the shortfall to "unexpected challenges" in SelectQuote's Medicare Advantage business.  In addition, SelectQuote updated its 2022 guidance to forecast a net loss of $255 million to $236 million. 

On this news, SelectQuote's stock price fell $2.99 per share, or 45.79%, to close at $3.54 per share on February 8, 2022.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.